Education Is Treatment: Integrating Chemosensory Dysfunction Education in Oncology Care

0Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Chemosensory dysfunction, defined as an altered or lost taste and smell, is a prevalent side effect of cancer treatment, with 93% of patients complaining of taste and 60% complaining of changes in smell. Despite their impact, it is an underrecognized symptom, impairing nutritional intake, quality of life, and treatment outcomes. Surprisingly, taste and smell changes are rarely assessed or addressed in oncology care. This commentary highlights the educational gap faced by clinicians and reports the results of a pilot educational intervention consisting of a 15-min podcast. The results indicate significant improvements in provider knowledge and confidence to support patients experiencing chemosensory dysfunction. By embedding chemosensory education into nutrition, survivorship, and interprofessional care pathways, clinicians can better recognize, document, and respond to these symptoms. Reframing taste and smell not as minor nuisances but as critical facets of patient well-being represents a shift toward more comprehensive oncology care.

Cite

CITATION STYLE

APA

Stromberg, K., Parma, V., Manley, K., Sherry, D., Hall, M. J., & Nolden, A. A. (2026). Education Is Treatment: Integrating Chemosensory Dysfunction Education in Oncology Care. Journal of Cancer Education, 41(3), 609–611. https://doi.org/10.1007/s13187-025-02641-y

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free